Regulatory Support

Conducts environmental impact studies and risk characterisation for pharmaceuticals and chemicals. Our ERA evaluations follow EMA, OECD, and national frameworks

Evaluates impurities, degradation products, and metabolites for toxicological safety and regulatory acceptance. Studies and risk assessments are designed to comply

Common Technical Document (CTD) Preparation for: Quality (Q) | Safety (S) | Efficacy (E) | Pharmacovigilance (M) Ensures all modules

Pre-IND Scientific Advice Meeting Preparation Provides end-to-end support for regulatory consultations, including data review, question framing, and meeting documentation. AAL’s